Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of Disc1 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Mouse,Rat |
| Host species | Rabbit |
| Applications | WB,IHC-P |
More info about Disc1 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB12144 |
| Product name: | Disc1 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of Disc1. |
| Gene id: | 244667 |
| Gene name: | Disc1 |
| Gene alias: | - |
| Gene description: | disrupted in schizophrenia 1 |
| Immunogen: | A synthetic peptide corresponding to amino acids 700-800 of mouse Disc1. |
| Protein accession: | Q811T9 |
| Form: | Liquid |
| Recommend dilutions: | Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (2.5-5 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris-glycine, 150 mM NaCl (0.05% sodium azide) |
| Storage instruction: | Store at -20°C or -80°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Mouse |
| Reactivity: | Mouse,Rat |
| Application image: |  |
| Application image note: | Staining of Disc1 on mouse brain neurons, glial cells, and white matter using Disc1 polyclonal antibody (Cat # PAB12144). |
| Applications: | WB,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders.Brandon NJ, Handford EJ, Schurov I, Rain JC, Pelling M, Duran-Jimeniz B, Camargo LM, Oliver KR, Beher D, Shearman MS, Whiting PJ. Mol Cell Neurosci. 2004 Jan;25(1):42-55. |